Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
EMA Decision Due For Minoryx’s Leriglitazone & Apellis’ Pegcetacoplan
Jan 22 2024
•
By
Eliza Slawther
The EMA's Human medicines committee will meet this week to decide which drugs should be approved in the EU • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Approvals
More from Product Reviews